Implementation of a High-Resolution Liquid Chromatography–Mass Spectrometry Method in Quality Control Laboratories for Release and Stability Testing of a Commercial Antibody Product
Author(s) -
Izabela Sokolowska,
Jingjie Mo,
Fatie Rahimi Pirkolachahi,
Carol McVean,
Lars A.T. Meijer,
Linda Switzar,
Crina I.A. Balog,
Michael Lewis,
Ping Hu
Publication year - 2019
Publication title -
analytical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.117
H-Index - 332
eISSN - 1520-6882
pISSN - 0003-2700
DOI - 10.1021/acs.analchem.9b05036
Subject(s) - chemistry , biopharmaceutical , chromatography , mass spectrometry , liquid chromatography–mass spectrometry , quality (philosophy) , product (mathematics) , resolution (logic) , process engineering , computer science , engineering , microbiology and biotechnology , artificial intelligence , philosophy , geometry , mathematics , epistemology , biology
Liquid chromatography-mass spectrometry (LC-MS) has been widely used throughout biotherapeutic development. However, its implementation in GMP-compliant commercial quality control (QC) laboratories remains a challenge. In this publication, we describe the covalidation and implementation of an automated, high-throughput, and GMP compliant subunit LC-MS method for monitoring antibody oxidation for commercial product release and stability testing. To our knowledge, this is the first report describing the implementation of a high-resolution LC-MS method in commercial QC laboratories for product release and stability testing in the biopharmaceutical industry. This work paves the road for implementing additional LC-MS methods to modernize testing in commercial QC with more targeted control of product quality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom